| Date Filed | Type | Description |
| 03/02/2023 |
4
| Moreland Mary K (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 5,926 shares
@ $99.77, valued at
$591.2k
Sold 717 shares
@ $100.77, valued at
$72.3k
|
|
| 02/22/2023 |
4
| Moreland Mary K (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 12,259 shares
@ $0
Granted 48,344 options to buy
@ $106.24, valued at
$5.1M
|
|
| 08/03/2022 |
4
| Moreland Mary K (EXECUTIVE VICE PRESIDENT) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 1,245 shares
@ $108.84, valued at
$135.5k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Moreland Mary K (Executive Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 1,244 shares
@ $100.64, valued at
$125.2k
|
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |